Treating tobacco dependency in cancer care: essential, cost-effective, and feasible, yet overlooked Epidemiology

被引：0
|
作者：
Sheikh, Mahdi [1 ]
Evison, Matthew [2 ,3 ]
机构：
[1] Int Agcy Res Canc IARC, WHO, Genom Epidemiol Branch, Lyon, France
[2] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Lung Canc & Thorac Surg Directorate, Southmoor Rd, Manchester M23 9LT, England
[3] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr MAHSC, Manchester, England
来源：
BRITISH JOURNAL OF CANCER | 2025年 / 132卷 / 07期
关键词：
CESSATION; SMOKING;
D O I：
10.1038/s41416-025-02957-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treating tobacco dependency in patients diagnosed with cancer delivers substantial benefits; improved overall survival, reduced risk of disease recurrence, less treatment-related adverse events and improved quality of life. This study by Mullen et al provides important data on cost-savings and return on investment from embedding tobacco dependency treatment within cancer care and is a call to arms for equitable access to these treatments for all patients diagnosed with cancer.
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [31] A cost-effective model for the pathway of care of CDH1-related hereditary diffuse gastric cancer syndrome (HDGC)
    Garrido, L.
    Sousa, L.
    Nercio, T.
    Castro, L.
    Leal, R.
    Costa, S.
    Magalhaes, A.
    Pereira, A. F.
    Guimaraes, R.
    Ferro, L.
    Vilarinho, L.
    Gullo, I.
    Pinheiro, H.
    Sousa, S.
    Neto, A. P.
    Capela, L.
    Caeiro, C.
    Augusto, I.
    Almeida, D.
    Pinto, G.
    Teixeira, C.
    Devezas, V.
    Macedo, G.
    Fougo, J. L.
    Preto, J.
    Barbosa, J.
    Costa-Maia, J.
    Baptista, M.
    Fernandes, S.
    Carneiro, F.
    Castedo, S.
    Oliveira, C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 624 - 625
  • [32] NGOs and Community oncology-Volunteers Module (NCVM): a novel cost-effective community model for tobacco induced cancer in resource poor Asian settings
    Shankhpal, P
    Narayanan, R
    Vaishall, P
    ANNALS OF ONCOLOGY, 2005, 16 : 300 - 300
  • [33] Critically appraised paper: Exercise is safe, clinically effective and cost-effective compared to usual care after non-reconstructive breast cancer surgery Commentary
    McNeely, Margaret L.
    Parkinson, Joanna
    JOURNAL OF PHYSIOTHERAPY, 2022, 68 (02) : 145 - 145
  • [34] Is adding ribociclib to fulvestrant cost-effective in treating postmenopausal women with HR+/HER2-advanced or metastatic breast cancer? A US payer perspective cost utility analysis
    Berrios, Kevin
    Burum, Alexandra
    Jeong, Eunae
    Zhong, Lixian
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (11): : 1282 - 1291
  • [35] Genetic Counselling followed by homologous recombination deficiency analysis in patients with newly diagnosed ovarian cancer is feasible and cost-effective in daily practice: A single centre retrospective study
    Schlootz, S.
    Saner, F.
    Rabaglio, M.
    Imboden, S.
    Wampfler, J.
    SWISS MEDICAL WEEKLY, 2023, 153 : 54S - 55S
  • [36] Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2-Advanced Breast Cancer in the USA?
    Wu, Wenhua
    Lin, Huiting
    Cai, Jiaqin
    Sun, Hong
    Liu, Jia
    Hu, Congting
    Wei, Xiaoxia
    CLINICAL DRUG INVESTIGATION, 2023, 43 (12) : 939 - 948
  • [37] Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2− Advanced Breast Cancer in the USA?
    Wenhua Wu
    Huiting Lin
    Jiaqin Cai
    Hong Sun
    Jia Liu
    Congting Hu
    Xiaoxia Wei
    Clinical Drug Investigation, 2023, 43 : 939 - 948
  • [38] Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial
    Farquhar, Morag C.
    Prevost, A. Toby
    McCrone, Paul
    Brafman-Price, Barbara
    Bentley, Allison
    Higginson, Irene J.
    Todd, Chris
    Booth, Sara
    BMC MEDICINE, 2014, 12
  • [39] Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial
    Morag C Farquhar
    A Toby Prevost
    Paul McCrone
    Barbara Brafman-Price
    Allison Bentley
    Irene J Higginson
    Chris Todd
    Sara Booth
    BMC Medicine, 12
  • [40] Community oncology-volunteers module [NCVM]: A novel cost-effective NGO model for tobacco-induced cancer in resource-poor Asian settings
    不详
    LUNG CANCER, 2005, 49 : S205 - S206
12345